RT Journal Article
SR Electronic
T1 Clinical efficacy landscaping in genetic obesity: A meta-analysis in Prader Willi syndrome (PWS)
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2024.08.02.24311335
DO 10.1101/2024.08.02.24311335
A1 Sarkar, Manish
A1 Horsten, Henning von
A1 Milunov, Dimitrije
A1 Lefebvre, Nathalie Barreto
A1 Saha, Soham
YR 2024
UL http://medrxiv.org/content/early/2024/08/05/2024.08.02.24311335.abstract
AB Genetic obesity such as Prader Willi syndrome (PWS) is a multifaceted condition influenced by various elements, including genetic predisposition, environmental factors, and behavioral components. This meta-analysis explored the reported efficacy of therapeutics in clinical trials for PWS by evaluating clinical endpoints reached in the course of the study and the adverse events observed for each. We looked at GLP1 receptor mediated and non-GLP1 receptor mediated therapies and compared their performance in study arms across time and standard of care. In addition, we estimated the present market shares across different obesity and diabetes assets which have been tested against PWS. In conclusion, the study points to two key readouts. First, existing obesity and diabetes assets are not effective for genetic obesity such as PWS. The unmet needs remain high. Second, the markets for obesity and diabetes are in a stage of expansion. A collaborative approach to therapy development for genetic obesity is required to improve the quality of life for affected individuals.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study did not receive any funding from external sources.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study used ONLY openly and publicly available clinical trials data that were originally located at clinicaltrials.govI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data are available in the main text or the supplementary materials.